Biotech · Private company
Advenchen Pharmaceuticals, LLC.
Track this companyFree. Adds Advenchen Pharmaceuticals, LLC. to your Dealase workspace and tells you when its record changes.
Clinical trials33 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- AL3818Phase 2 · Endometrial NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- AL58805Phase 2 · Endometrial NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- AL8326Phase 2 · Endometrial NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- AL8326 40 mgPhase 2 · Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- AL8326 60 mgPhase 2 · Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- AL8326 80 mg--stoppedPhase 2 · Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- CCNUPhase 2 · Endometrial NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- EribulinPhase 2 · Endometrial NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- FulvestrantPhase 2 · Endometrial NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- Temozolomide (TMZ)Phase 2 · Endometrial NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of AL58805 in Advanced, Metastatic GYN, STS or Breast CancersPHASE1_PHASE2 · NOT_YET_RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07811232 · fetched Nov 12, 2026
- A Study of Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM CancersPHASE1_PHASE2 · NOT_YET_RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07811297 · fetched Nov 12, 2026
- Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More TreatmentPHASE2 · RECRUITING · started Nov 1, 2022ClinicalTrials.gov NCT05363280 · fetched Nov 12, 2026